Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KY-556 is a promising and orally-active pro-drug of disodium cromoglycate (DSCG). It also against allergic diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | 6-8 weeks | $ 789.00 | |
100 mg | 6-8 weeks | $ 1,240.00 |
Description | KY-556 is a promising and orally-active pro-drug of disodium cromoglycate (DSCG). It also against allergic diseases. |
In vivo | N-556, administered orally at a dosage of 100 mg/kg, has been shown to extend survival times in rats experiencing systemic anaphylaxis and to significantly reduce airway resistance in rat models of experimental asthma. Furthermore, N-556 demonstrated a dose-dependent inhibition of 48-hour homologous passive cutaneous anaphylaxis (PCA) in rats, with effects persisting longer than those observed with Disodium cromoglycate (DSCG) administered intravenously. The compound's oral anti-allergic properties were further confirmed through a regimen of 20 and 100 mg/kg daily for 20 days, which notably suppressed histamine release from lung fragments of actively sensitized rats. |
Synonyms | N556 |
Molecular Weight | 689.11 |
Formula | C33H37ClN2O12 |
CAS No. | 110816-78-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KY-556 110816-78-9 Others KY556 N-556 N 556 N556 KY 556 inhibitor inhibit